Drug Search Results
More Filters [+]

CI-532

Alternative Names: ci-532, ci532, ci 532
Latest Update: 2024-01-01
Latest Update Note: PubMed Publication

Product Description

Cochlear implant for sensorinueral hearing loss (Sourced from: https://mss-p-007-delivery.sitecorecontenthub.cloud/api/public/content/03cc45c59ef547cfa66dc72845c0961b?v=a6ad9f84&MOD=AJPERES&CVID=mlnL-Hq&useDefaultText=0&useDefaultDesc=0&CVID=mlnL-Hq)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cochlear
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CI-532

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CLTD5626

N/A

Completed

Hearing Loss

2019-07-15

SME

N/A

Completed

Hearing Loss, Sensorineural

2018-12-03

CEL5661

N/A

Completed

Deafness|Hearing Loss

2018-08-28

CAM5631

N/A

Terminated

Hearing Loss

2017-08-23

Recent News Events